Related Experiment Video
Updated: Sep 20, 2026

Measuring Cardiac Autonomic Nervous System (ANS) Activity in Children
Published on: April 29, 2013
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block
R Cimaz1, M Stramba-Badiale, A Brucato
1Instituti Clinici di Perfezionamento, Milan, Italy.
Insights
Infants born to mothers with anti-SSA/Ro antibodies may experience QT interval prolongation. Electrocardiogram (EKG) monitoring is recommended for these newborns to detect potential cardiac issues.
Area of Science:
- Cardiology
- Immunology
- Neonatology
Background:
- Maternal autoantibodies, specifically anti-SSA/Ro, can cross the placenta.
- Potential cardiac effects of these antibodies on newborns are not fully understood.
Observation:
- Electrocardiograms (EKGs) were analyzed in infants born to mothers with and without anti-SSA/Ro antibodies.
- QT interval, a measure of cardiac repolarization, was assessed and corrected for heart rate (QTc).
Findings:
- Infants with maternal anti-SSA/Ro antibodies exhibited significantly prolonged QTc intervals compared to controls.
- A notable proportion of anti-SSA/Ro-positive infants had QTc values exceeding the normal range, confirmed by Holter monitoring.
- QT prolongation suggests potential cardiac electrical abnormalities in these infants.
Implications:
- Neonates exposed to maternal anti-SSA/Ro antibodies require vigilant EKG surveillance.
- Early detection of QT prolongation can guide preventative management, such as beta-blocker therapy, to mitigate arrhythmia risks.
Objective:
To analyze the electrocardiograms (EKGs) of infants born to mothers with anti-SSA/Ro antibodies in order to evaluate the QT interval (the time from the beginning of the QRS complex to the end of the T wave).
Methods:
Sera from mothers and children were analyzed for anti-Ro and anti-SSB/La antibodies by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. Fine specificity of anti-Ro antibodies was evaluated by solid-phase ELISA against recombinant 52- and 60-kd proteins and by Western blot. A retrospective chart review was conducted for EKG analysis. Twenty-eight EKG tracings (21 from anti-Ro-positive and 7 from anti-Ro-negative infants born to mothers with autoimmune diseases) were analyzed by a single investigator who was blinded to the infant's antibody status. The QT interval was measured and corrected for heart rate according to Bazett's formula.
Results:
The mean QT interval was significantly longer in anti-Ro-positive than in anti-Ro-negative infants, also after correction for heart rate (QTc) (P = 0.001). Nine of 21 anti-Ro-positive infants and 0 of 7 anti-Ro-negative infants had QTc values above the upper normal limit (440 msec). A 24-hour EKG recording was performed on 5 patients and confirmed the QT prolongation. These infants were subsequently treated with a beta-blocker in order to prevent arrhythmias.
Conclusion:
Infants born to mothers who carry anti-Ro autoantibodies may show QT interval prolongation and should be monitored with EKG during the first months of life.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Respiratory Syncytial Virus Disease

